Literature DB >> 31469912

Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU.

Ragıp Ertaş1, Tomasz Hawro2, Sabine Altrichter2, Kemal Özyurt1, Kemal Erol3, Şule Ketenci Ertaş4, Marcus Maurer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31469912     DOI： 10.1111/all.14033

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  4 in total

Review 1.  Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Authors:  Liting He; Wanyu Yi; Xin Huang; Hai Long; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-16       Impact factor: 8.667

Review 2.  Critical Points on the Use of Biologicals in Allergic Diseases and Asthma.

Authors:  Ioana Agache; Catalina Cojanu; Alexandru Laculiceanu; Liliana Rogozea
Journal:  Allergy Asthma Immunol Res       Date:  2020-01       Impact factor: 5.764

3.  Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU).

Authors:  Jae-Hyuk Jang; Eun-Mi Yang; Youngsoo Lee; Young-Min Ye; Jiyoung Moon; Min Sook Ryu; Hae-Sim Park
Journal:  World Allergy Organ J       Date:  2022-02-12       Impact factor: 4.084

4.  Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria.

Authors:  Jae-Hyuk Jang; Jiyoung Moon; Eun-Mi Yang; Min Sook Ryu; Youngsoo Lee; Young-Min Ye; Hae-Sim Park
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.